[Skip to Content]
[Skip to Content Landing]

Age Disparities Among Cancer Clinical Trial Participants

A 2019 study reported that cancer trial participants are a mean 6.5 years younger than the true cancer population treated in practice, especially in industry-funded trials and those testing a targeted therapy. The findings suggest the evidence base for cancer therapeutics is not applicable to the broader patient population. JAMA Oncology Editor Mary (Nora) Disis, MD, of the University of Washington in Seattle explains the significance of the findings to JAMA Medical News senior staff writer Jennifer Abbasi.

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Name Your Search

Save Search

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Topics
State Requirements